SPECIFIC PHARMA A/S: Financial statements 2022
CVR: 33161395
Source: annual report 2022, Danish Business Authority
01/02/2021 – 31/01/2022
SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 123,270,000 and a net result of DKK 7,769,000 compared with DKK 14,799,000 the year before. That is a decrease of 11.7% compared with the year before. The profit margin was 6.3%. Equity in the 2022 report amounted to DKK 85,488,000. The solvency ratio was 82.9%. The company had 23 employees in the financial year.
- Revenue
- DKK 123,270,000
- Gross Profit
- DKK 26,382,000
- Profit/Loss
- DKK 7,769,000
- Equity
- DKK 85,488,000
- Total Assets
- DKK 103,079,000
- Employees
- 23
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 123.3 mio. | 26.4 mio. | 7.8 mio. | 85.5 mio. | 23 |
| 2021 | 139.6 mio. | 32.5 mio. | 14.8 mio. | 88.8 mio. | 21 |
| 2020 | 128.2 mio. | 27 mio. | 8.2 mio. | 80.2 mio. | 16 |
| 2019 | 146.4 mio. | 25.3 mio. | 8.9 mio. | 78.6 mio. | 15 |
| 2018 | 145.7 mio. | 29.7 mio. | 14.8 mio. | 69.7 mio. | 12 |
Official annual report
Keep an eye on SPECIFIC PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout SPECIFIC PHARMA A/S
SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The board consists of Kristine Sakstrup Haag (chair), Henrik Kaastrup, Kasper Casparij Yde and Ken Rasmussen. The company is owned by NOMECO A/S. The company has 24 employees (2018). In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity in the 2026 report amounted to DKK 98,645,000.